Treatment with (r)-albuterol Has No Advantage over Racemic Albuterol Detrimental Effects of B 2 -agonists

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of formoterol over 24 h in patients with asthma: the role of enantiomers.

  2005cited by this paper
• Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.

  2005cited by this paper
• Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity

  2005cited by this paper
• Levalbuterol Versus Racemic Albuterol in the Treatment of Acute Exacerbation of Asthma in Children

  2005cited by this paper
• Past, present and future--beta2-adrenoceptor agonists in asthma management.

  2005cited by this paper
• Single-isomer R-salbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness.

  2004cited by this paper
• COMPARISON OF RACEMIC ALBUTEROL AND LEVALBUTEROL FOR TREATMENT OF ACUTE ASTHMA

  2004cited by this paper
• (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells.

  2004cited by this paper
• Modeling asthma and COPD in animals: a pointless exercise?

  2003cited by this paper
• Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer.

  2002cited by this paper
• β2-Agonist Tolerance and Exercise-induced Bronchospasm

  2002cited by this paper
• Overexpression of matrix metalloproteinase‐8 and ‐9 in bronchiectatic airways in vivo

  2002cited by this paper
• Adverse effects of beta-agonists.

  2002cited by this paper
• Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey.

  2001cited by this paper
• The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.

  2001cited by this paper
• (S)-Albuterol Increases the Production of Histamine and IL-4 in Mast Cells

  2001cited by this paper
• Levalbuterol and racemic albuterol: are there therapeutic differences?

  2001cited by this paper
• Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.

  2001cited by this paper
• Low-dose inhaled corticosteroids and the prevention of death from asthma.

  2000cited by this paper
• The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.

  1999cited by this paper
• Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

  1999cited by this paper
• Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects.

  1999cited by this paper
• Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma

  1999cited by this paper
• Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.

  1999cited by this paper
• Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol.

  1999cited by this paper
• Effect of beta-agonists on inflammatory cells.

  1999cited by this paper
• Contrasting properties of albuterol stereoisomers.

  1999cited by this paper
• Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.

  1998cited by this paper
• (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle.

  1998cited by this paper
• Effects of S-salbutamol on human isolated bronchus.

  1998cited by this paper
• Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils.

  1997cited by this paper
• Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.

  1996cited by this paper
• Differential responses of asthmatic airways to enantiomers of albuterol

  1996cited by this paper
• Functional desensitization of beta agonist responses in human lung mast cells.

  1995cited by this paper
• Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of beta 2-selective sympathomimetics.

  1994cited by this paper
• Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

  1993cited by this paper
• Regular inhaled salbutamol and airway responsiveness to allergen.

  1993cited by this paper
• Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma

  1992cited by this paper
• Regular inhaled beta-agonist treatment in bronchial asthma

  1991cited by this paper
• Banks ALBUTEROL AND EFFICACY IN COMPARISON WITH PLACEBO AND RACEMIC LOW-DOSE LEVALBUTEROL IN CHILDREN WITH ASTHMA : SAFETY Services

  year unknowncited by this paper

• No citing papers are available for this paper.